Compare ABCL & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | WINA |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2020 | 2006 |
| Metric | ABCL | WINA |
|---|---|---|
| Price | $9.44 | $371.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.40 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 37.8K |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 3.76% |
| EPS Growth | ★ 10.91 | 3.76 |
| EPS | N/A | ★ 5.31 |
| Revenue | $75,128,000.00 | ★ $86,055,700.00 |
| Revenue This Year | N/A | $5.55 |
| Revenue Next Year | $21.85 | $6.03 |
| P/E Ratio | ★ N/A | $70.82 |
| Revenue Growth | ★ 160.56 | 5.86 |
| 52 Week Low | $2.75 | $325.06 |
| 52 Week High | $10.01 | $526.81 |
| Indicator | ABCL | WINA |
|---|---|---|
| Relative Strength Index (RSI) | 77.04 | 53.24 |
| Support Level | $3.38 | $362.23 |
| Resistance Level | N/A | $397.91 |
| Average True Range (ATR) | 0.51 | 12.21 |
| MACD | 0.29 | 4.04 |
| Stochastic Oscillator | 87.97 | 97.87 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.